Investment Banking

Evercore lands role on $10.1bn Nestlé deal

Win is a boost for Evercore and comes as boutiques’ steady march onto larger rivals’ turf has paused in 2019

Nestlé Skin Health owns Galderma, a pharmaceutical company specialising in dermatological treatments, including Dysport (botox), which is being demonstrated at an event
Nestlé Skin Health owns Galderma, a pharmaceutical company specialising in dermatological treatments, including Dysport (botox), which is being demonstrated at an event Photo: Cooper Neill/Getty Images

Evercore has landed a role advising Nestlé on the $10.1bn sale of its Skin Health business to a consortium of private equity firms, a boost to the company after a difficult first quarter for boutique investment banks.

The boutique bank is advising Nestlé alongside Credit Suisse on the transaction, with a group of private equity firms led by EQT and a subsidiary of the Abu Dhabi Investment Authority winning the fiercely contested deal.

WSJ Logo
How Trump Got His ‘Big, Beautiful Bill’ Across the Finish LineExternal link

How Trump Got His ‘Big, Beautiful Bill’ Across the Finish Line